Shafi et al. observed SLE patients on HD during a 1-year period where patients with positive aCL antibodies had a statistically significantly higher rate of VAT (83.3%) as opposed to patients with negative aCL antibodies (33.3%)4. This evidence concerns the gene ACLY and systemic lupus erythematosus.